ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
On August 13, ADC Therapeutics (NYSE:ADCT) held its second-quarter earnings call and delivered a mixed message that investors are still sorting through.
Adc Therapeutics Sa (ADCT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 12,326,184 | $13,189,017 | +121% | 0.43% |
| 2. | Redmile Group Jeremy Green | 11,526,710 | $12,333,580 | -26% | 0.83% |
| 3. | Prosight Capital Lawrence Hawkins | 7,824,749 | $8,372,481 | -6% | 1.44% |
| 4. | Point72 Asset Management Steve Cohen | 3,649,144 | $3,904,584 | +8% | 0% |
| 5. | Millennium Management Israel Englander | 2,899,535 | $3,102,502 | -8% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.81 | 50,000 | $190,500.00 | 13,145,712 | 2024-12-11 | Filing | |
| $2.28 | 50,000 | $114,000.00 | 13,095,712 | 2024-12-11 | Filing | |
| $3.81 | 50,000 | $190,500.00 | 15,666,731 | 2024-12-11 | Filing | |
| $2.28 | 50,000 | $114,000.00 | 15,616,731 | 2024-12-11 | Filing | |
| $2.81 | 400,000 | $1,124,000.00 | 12,995,040 | 2024-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.28 | 2,529,491 | $8,294,200.99 | 10,265,297 | 2026-04-02 | Filing | |
| $3.28 | 2,634,506 | $8,638,545.17 | 12,666,731 | 2026-04-02 | Filing | |
| $3.80 | 162,517 | $617,402.08 | 12,794,788 | 2026-04-01 | Filing | |
| $3.80 | 169,265 | $643,037.74 | 15,301,237 | 2026-04-01 | Filing | |
| $3.75 | 188,407 | $706,903.06 | 12,957,305 | 2026-03-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,390,175 | $12,187,487 | 0.29% | |
| 2. | 7,020,093 | $7,511,500 | 0% | |
| 3. | 3,051,173 | $3,264,755 | 0% | |
| 4. | 1,914,424 | $2,048,434 | 0% | |
| 5. | 1,685,836 | $1,803,845 | 0% |
News See All
ADC Therapeutics S.A. (NYSE:ADCT) Q1 2026 Earnings Call Transcript
ADC Therapeutics S.A. (NYSE:ADCT) Q1 2026 Earnings Call Transcript May 4, 2026ADC Therapeutics S.A. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.19.
13 Best Growth Stocks to Buy Right Now
In this article, we will discuss the 13 Best Growth Stocks to Buy Right Now.
RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development
ADC Therapeutics (NYSE:ADCT) is one of the best multibagger penny stocks to buy right now.
14 Best Multibagger Penny Stocks to Buy Right Now
This article looks at the 14 Best Multibagger Penny Stocks to Buy Right Now. The Russell 2000 Index has hit fresh highs heading into 2026, signaling renewed interest in small companies.
ADC Therapeutics S.A. (NYSE:ADCT) Q3 2025 Earnings Call Transcript
ADC Therapeutics S.A. (NYSE:ADCT) Q3 2025 Earnings Call Transcript November 10, 2025ADC Therapeutics S.A. beats earnings expectations. Reported EPS is $-0.30023, expectations were $-0.4.
ADC Therapeutics (ADCT) Secures PIPE Financing, Price Target Adjusted
ADC Therapeutics S.A. (NYSE:ADCT) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 16, H.C.
Billionaire Steve Cohen's 10 Small-Cap Stock Picks with Huge Upside Potential
In this article, we will examine Billionaire Steve Cohen's 10 Small-Cap Stock Picks with Huge Upside Potential.
H.C. Wainwright Lowers ADC Therapeutics (ADCT) PT to $7 Following $60M Private Placement
ADC Therapeutics (NYSE:ADCT) is one of the best long term penny stocks with huge upside potential. On October 16, H.C.
10 Best Long Term Penny Stocks with Huge Upside Potential
On October 2, Dan Veru, Palisade Capital Management senior partner and CIO, joined 'Power Lunch' on CNBC to discuss the opportunities available in small-cap stocks and talk about the start of the first...
Hedge Fund Resource Center